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Objetivo. El objetivo del presente estudio era desarrollar un método de análisis que permitiera 
estimar la cantidad de fármaco en forma combinada  sin separación previa.
Material y Método. Se utilizó espectroscopía colorimétrica UV para la determinación de Amlodipino 
Besilato (AML) plasmático 
Resultados. El presente método está basado en la formación de color verde en la reacción entre 
Amlodipino Besilato (AML) y cloruro férrico 0,4% y ferrocianuro potásico 0,2%. La medida de la 
absorbancia se realizó a 775nm.  El resultado del análisis de los comprimidos mostró unos valores 
de DE comprendidos entre 098,22 y 100,63%. El valor de la DE utilizando metanol oscilan entre 98,01 
y 101,13%  lo que demuestra la capacidad del método de permanecer inalterado por pequeños pero 
intencionados cambios en las condiciones de la reacción, este método es usado para la estimación de 
Amlodipino Besilato (AML) en muestras biológicas.
PALABRAS CLAVE: Amlodipino Besilato (AML), método colorimétrico
ABSTRACT 
Aim: The present work was to develop the method of analysis which can estimate drug in combined 
form without prior separation. 
Materials and method: By using UV spectroscopy colorimetric method was used for determination 
of Amlodipine besylate (AML) from plasma. 
Result and conclusion: This method is based on the formation of green colour in reaction between 
AML and 0.4 % Ferric chloride (FC) and 0.2 % Potassium ferricyanide (PF).The absorbance was 
measured at 775 nm. Result of tablet analysis showed % S.D. values in the range of 098.22 to 100,63%. 
Standard deviation value for tablet analysis by using methanol ranging from 98.01 to 101,13 % which 
proves the ability of the method to remain unaffected by small but deliberate change in reaction 
conditions and this method is used for estimation of AML from biological samples.  
KEY WORDS: Amlodipine besylate, colorimetric method. 
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INTRODUCTION:
Market survey revealed that, day by day new drugs and 
their combination with another drugs are being introduced 
in market as they have more patient compliance than a 
single drug. The analytical chemistry hence has challenge 
in developing the methods for their analysis with the help 
of number of analytical techniques which are available 
for the estimation of the drugs and their combination. 
Analytical Chemistry involves separations, identification 
and determination of the relative amount of the component 
in a sample matter. In Analytical Chemistry ‘Quality’ is 
associated with accuracy and reproducibility; other criteria 
can be cost, speed and information. Analytical monitoring 
of pharmaceutical product or of specific ingredients within 
the product is necessary to ensure the safety and efficacy 
throughout the shelf life, including storage, distribution and 
use.1 In general terms pharmaceutical analysis comprises, 
those procedures necessary to determine the identity, 
strength, quality and purity of drugs and chemicals.
Amlodipine Besylate (AML) which is widely used in 
the treatment of hypertension. Amlodipine Besylate is 
chemically 2-[(2-aminoethoxy) methyl]-4-(2-chlorophenyl)-
1,4dihydro-6-methyl-3,5- pyridine dicarboxylic acid -3 
ethyl-5- methyl ester monobenzene sulphonate and it is a 
peripheral arterial vasodilator that acts directly on vascular 
smooth muscle to cause a reduction in peripheral vascular 
resistance and reduction in blood pressure. 
There are various methods for AML alone or in 
combination with other dosage form such as HPLC 1-7, UV 
8-10 for simultaneous estimation. But there is no method 
reported for simultaneous estimation of AML from plasma 
by colorimetric estimation by using 0.4 % Ferric chloride 
(FC) and 0.2 % Potassium ferricyanide (PF). In the analysis 
of formulations containing two or more drugs, one drug 
can interfere in the estimation of another drug. To avoid 
this, separation of components of mixture by extraction 
is usually carried out which make the procedure time 
consuming and complicated and often lacks accuracy.
The present work was undertaken to develop such 
method of analysis, which can estimate both the drugs in 
combination without prior separation which is a precise, 
accurate, simple, reliable and less time consuming method 
for estimation of drugs in plasma.
METHOD
Apparatus:
The instrument used for the present study was PC based 
Jasco V-530 UV-Visible double beam Spectrophotometer 
with 1 cm matched pair quartz cell and spectral bandwidth 
of 2 nm.
Reagents and materials:
Amlodipine Besylate was obtained as a gift sample from 
Cipla, Vapi, India. Ferric chloride and 0.2 % Potassium 
ferricyanide were purchased from Loba fine, India. Double 
distilled water was used throughout the experiment. 
Amlostat-5 in a tablet dosage form containing AML was 
purchased from local commercial sources.
Selection of Reagent:
Ferric chloride and Potassium ferricyanide were selected 
as a reagent for developing colorimetric reaction. The 
selection of reagents was made on the basis of functional 
groups present on the chemical structure of drug.
Optimization of Reagents and Reaction Conditions:
Temperature of reaction, quantity, concentration and 
sequence of addition of reagents were optimized after 
several experimental trails. 1 ml each of FC and PF having 
concentration of 0.4 % and 0.2 % respectively was found 
to be optimum for completion of reaction. The stability of 
formed complex was checked by recording the absorbance 
of the solution after an interval of 2 hours over a period of 
52 hours.
Preparation of Standard Stock Solutions:
To the 2.5 ml of blood sample 0.5 ml of 0.1 M acetic acid was 
added. RBC allows settling down. Sample was centrifuged 
at 5000 r.p.m. for 35 min. The supernatant was collected 
as plasma. To the 20 ml solution of weight sample of drug 
(AML separately) dissolved in methanol, 2 ml of plasma 
solution was added. Obtained 22 ml solution was filtered 
through syringe filter of size 45 µm size. Final volume 
was adjusted to 100 ml with solvent to get stock solution 
containing 100 μg/ml of AML. Solution of FC (0.4 %) was 
prepared by dissolving 200 mg of FC in 30 ml of 1 N HCl 
and the final volume was made up to 50 ml with the same 
solvent. Solution of PF (0.2 %) was prepared by dissolving 
100 mg of PF in 30 ml of double distilled water. It was then 
sonicated for 5 minutes and the final volume was made up 
to 50 ml with the same.
Procedure for Plotting Calibration Curve:
Appropriate aliquots of standard drug solution were taken 
into a series of 10 ml volumetric flasks. To each volumetric 
flask 1 ml of FC (0.4 %) and 1 ml of PF (0.2 %) was added 
and the solutions were kept for 10 minutes to complete the 
reaction. Completion of reaction was indicated by change in 
the color of solution from colorless to yellow to green. The 
volume was then made up to 10 ml with double distilled 
water to get final concentrations of 2.5, 5, 7.5, 10, 12.5, and 
15µg/ml. The absorbance of the green colored species was 
measured at 775 nm against reagent blank. Calibration 
curve was constructed at the same wavelength by using 
Microsoft Excel® software, intercept, slope and coefficient 
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Table 1. Optical characteristics:
Figure 1. Overlain spectra of AML- reagent complex and 
reagent.
Figure 2. Overlain spectra of AML – reagent complex.
of correlation values for calibration curve were obtained. 
Overlain spectra of drug, reagent and complex are shown 
in Figure 1 Overlain spectra of all the concentrations of 
drug used for calibration curve are shown in Figure 2 and 
Optical characteristics are shown in Table 1.
Analysis of Formulation:
Marketed tablet formulation (AML 10 mg) procured from 
a local pharmacy was analyzed using this method. Twenty 
tablets were accurately weighed and average weight was 
calculated. The tablets were ground to a fine powder. An 
accurately weighed tablet powder equivalent to 10 mg of 
AML was dissolved in 15 ml of methanol. The contents 
were ultrasonicated for 10 minutes. The solution was 
then filtered through Whatmann filter paper No.41 and 
previously separated 1 ml plasma solution was added. The 
solution was filtered through hydrophilic PVDF 45µm size 
syringe filter. Final volume was made up to 50 ml with 
solvent. . Appropriate aliquots within the Beer’s law limit 
suitable concentration were prepared and analyzed. The 
concentration of AML present in the sample solution was 
calculated by using the formula: Abs = A + B* C where, A = 
0.0032, B = 0.0316 and C = concentration of AML.
Parameters Values for AML
Beer’s law limit (μg/ml)    2-30
Correlation coefficient   0.9995
Regression equation (Y*)
Slope (B)  0.0316
Intercept (A)  0.0032
Y= A + B*C, where C is the concentration in µg/ml and 
Y is absorbance unit.
Accuracy and Precision Study:
Accuracy has been calculated as per USFDA guidelines, by 
analyzing control samples, (five determinations per three 
concentrations) spiked with analyte and by comparison 
of analytical method with reference method. Results 
of accuracy and precision studies are given in Table 2. 
Acceptance criteria: At LLOQ ± 20 % of actual spiked 
concentrations, other than LLOQ ± 15% of actual spiked 
concentrations.
Recovery Studies:
Accuracy of analysis was determined by performing 
recovery studies by spiking different concentrations of 
pure drug in the preanalyzed tablet samples within the 
analytical concentration range of the proposed method 
at three different set at level of 80%, 100% and 120%. The 
added quantities of the individual drugs were estimated by 
above method. The results indicated excellent recoveries 
ranging from 98.77 to 100.48 %.     
Method validation:
The method was validated according to USFDA guidelines 
for validation of analytical procedures in order to determine 
the LOQ, LLOQ, stability for the analyte. Results are shown 
in Table 3.
MQC-medium quality control concentrations, 50% of 
largest concentrations of calibration curve  
HQC- high quality control concentrations, 75-90% of largest 
concentrations of calibration curve  
% recovery= (Mean response of extracted samples / Mean 
response of unextracted samples) × 100
Acceptance criteria: 
Doijad RC,  Sankpal PS,  More HN,  Pishwikar SA, Pathan AB, Suryawanshi GB.
Ars Pharm. 2013; 53(4): 01-06.
5
Table 2. Results of Accuracy and Precision study.
Table 3. Result of Short term stability.
Analyte Concentration level
% concentration found* (Accuracy)
(Mean ± SD) R.S.D.
AML
T1
LLOQ 1  89.79± 4.3340 5.4338
Other than LLOQ
2 85.52± 5.7603 7.1502
3 86.54± 4.7432 5.8134
T2
LLOQ 1 89.69± 7.6748 8.8802
Other than LLOQ
2 86.64± 7.5427 8.4854
3 86.66±4.6780 5.6044




Low 3 99.56± 1.3479
High 28 98.94 ± 0.2166
* Average of four determinations, SD. Standard Deviation.
* Average of four determinations, SD. Standard Deviation.
1) Accept only methods giving > 50% recovery for the 
method validation.
2)  CV% of areas of analyte and IS shall be < 20%
RESULTS AND DISCUSSION:
The method employs Ferric chloride (FC) in 1 N HCl and 
potassium ferricyanide (PF) to form green colored complex 
with AML. The absorption peaks of reagent and the 
complex are located at 775 nm respectively. Temperature of 
reaction, quantity, concentration and sequence of addition 
of reagents were optimized after several experimental trials. 
The optimum quantity and concentration of ferric chloride, 
PF was found to be 1 ml, 1 ml and 0.4 %, 0.2 % respectively. 
The results showed that optimal condition for the reaction 
of Ferric chloride with AML is in an acidic medium. Thus 
the effect of hydrochloric acid, sulphuric acid and nitric 
acid was studied on the color reaction. The experiments 
showed that the results obtained by using hydrochloric acid 
were superior to other acids. Concentration and quantity 
of PF was optimized to 0.2 % and 1 ml respectively. AML 
was found to obey Beer’s law in the concentration range 
2 to30µg/ml employed for analysis. After mixing the 
components the absorbance reaches its maximum within 
10 minutes at room temperature and remains stable for 48 
hours. 
         Result of analysis of tablet formulation showed % .S.D. 
values in the range of 098.22 to 100.63, % which indicates 
high precision of the method. The results indicated 
excellent recoveries ranging from 98.77 to 100.48 %. 
Recoveries obtained for the drug do not differ significantly 
from 100% showing that there was no interference from 
common excipients used in the formulation and thus 
indicates accuracy and reliability of the method. Interday 
and intraday studies show high degree of repeatability of 
an analytical method under normal operational conditions. 
Limit of detection was found to be 0.56 μg/ml and limit 
of quantitation was found to be 0.67 μg/ml.For testing of 
robustness of the method the different ratio of methanol 
show adjacent absorbance. Standard deviation value for 
tablet analysis was ranging from 98.14 to 101.13 %.and 
R.S.D. was found to be 0.76 % standard deviation value 
for tablet analysis by using methanol Solution was found 
to be ranging from 98.01 to 101.13 % for AML which 
proves the ability of the method to remain unaffected 
by small but deliberate change in reaction conditions. 
Estimation of Amlodipine Besylate from plasma by using 
same procedure shows efficient application of developed 
method in estimation AML from biological samples.  
CONCLUSION:
The proposed method has the advantages of simplicity, 
rapidity and selectivity. Low LOD and LOQ indicate that 
very small quantities of drug can be estimated by this 
method. The assay method involve less stringent control 
of experimental parameters such as time of analysis, the 
stability of the colored species, and the concentration of 
the reagent. The method has been validated successfully 
according to USFDA bioanalytical guidelines. Estimation 
of AML from biological samples which can be applied for 
bioequivalence and pharmacokinetic study. 
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